Preferred Name |
Dasatinib Anhydrous |
|
Synonyms |
|
|
Definitions |
An orally bioavailable synthetic small molecule-inhibitor of SRC-family protein-tyrosine kinases. Dasatinib binds to and inhibits the growth-promoting activities of these kinases. Apparently because of its less stringent binding affinity for the BCR-ABL kinase, dasatinib has been shown to overcome the resistance to imatinib of chronic myeloid leukemia (CML) cells harboring BCR-ABL kinase domain point mutations. SRC-family protein-tyrosine kinases interact with variety of cell-surface receptors and participate in intracellular signal transduction pathways; tumorigenic forms can occur through altered regulation or expression of the endogenous protein and by way of virally-encoded kinase genes. |
|
ID |
http://purl.obolibrary.org/obo/NCIT_C74556 |
|
CAS_Registry |
302962-49-8 |
|
CHEBI_ID |
CHEBI:49375 |
|
Chemical_Formula |
C22H26ClN7O2S |
|
code |
C74556 |
|
Contributing_Source |
CTRP FDA |
|
definition |
An orally bioavailable synthetic small molecule-inhibitor of SRC-family protein-tyrosine kinases. Dasatinib binds to and inhibits the growth-promoting activities of these kinases. Apparently because of its less stringent binding affinity for the BCR-ABL kinase, dasatinib has been shown to overcome the resistance to imatinib of chronic myeloid leukemia (CML) cells harboring BCR-ABL kinase domain point mutations. SRC-family protein-tyrosine kinases interact with variety of cell-surface receptors and participate in intracellular signal transduction pathways; tumorigenic forms can occur through altered regulation or expression of the endogenous protein and by way of virally-encoded kinase genes. |
|
Display_Name |
Dasatinib Anhydrous |
|
FDA_UNII_Code |
X78UG0A0RN |
|
Has_Target |
http://purl.obolibrary.org/obo/NCIT_C26156 http://purl.obolibrary.org/obo/NCIT_C17328 http://purl.obolibrary.org/obo/NCIT_C16325 |
|
in_subset |
http://purl.obolibrary.org/obo/NCIT_C63923 |
|
label |
Dasatinib Anhydrous |
|
Legacy Concept Name |
Dasatinib_Anhydrous |
|
Preferred_Name |
Dasatinib Anhydrous |
|
prefixIRI |
NCIT:C74556 |
|
prefLabel |
Dasatinib Anhydrous |
|
Semantic_Type |
Pharmacologic Substance |
|
UMLS_CUI |
C2699562 |
|
subClassOf |